Sponsors (10)
Introduced December 3, 2025 by John Wright Hickenlooper · Last progress December 3, 2025
The bill strengthens scientific standards, transparency, and funding for federal vaccine recommendations and injury-table decisions—improving predictability and access—while trading off added taxpayer cost, tighter legal and evidentiary constraints that can slow or complicate updates (and prompt litigation), and deadlines or statutory adoption rules that may reduce flexibility or risk rushed guidance.
Patients, clinicians, and public-health programs will see vaccine policy and compensation decisions governed by a stronger, explicit scientific standard (a required 'preponderance of the best available, peer‑reviewed evidence'), producing more evidence‑based ACIP recommendations and Vaccine Injury Table changes.
Children (including those eligible for Vaccines for Children) and Medicaid beneficiaries will have clearer statutory immunization schedules and VFC purchasing/coverage rules, improving vaccine access and program predictability.
Newly licensed vaccines and new vaccine indications will be considered on an accelerated timeline (statutory 90‑day recommendation deadline), which can speed availability and uptake of newly authorized vaccines for patients who need them.
Raising and codifying a stringent 'preponderance of the best available scientific evidence' standard risks slowing removals or updates to the Vaccine Injury Table, increasing litigation and administrative burdens, and—if applied conservatively—keeping outdated compensable items on the Table or discouraging manufacturers.
The 90‑day statutory deadline for ACIP recommendations could pressure deliberations and lead to rushed or less‑thorough guidance on complex evidence, risking poorer clinical/public‑health decisions.
The bill authorizes federal appropriations (about $2.8M/year) to fund ACIP operations, a recurring taxpayer cost and addition to budgetary demands.
Based on analysis of 3 sections of legislative text.
Codifies ACIP into statute, requires vaccine recommendations and Vaccine Injury Table changes to meet a preponderance of peer‑reviewed scientific evidence, and sets timelines and publication/notification duties.
Creates statutory rules for how the federal vaccine advisory committee and HHS must handle vaccine recommendations and changes to the Vaccine Injury Table. It codifies the Advisory Committee on Immunization Practices into the Public Health Service Act, requires decisions to be based on a preponderance of the best available peer‑reviewed scientific evidence, sets timelines and publication/notification duties for the CDC Director and the Committee, and requires that removals or other modifications to the Vaccine Injury Table meet the same evidentiary standard.